Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

Indian pharmaceutical companies will be able to retain their dominant market share in the U.S. in selling generic drugs even ...

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by ...

BISMARCK, N.D. (North Dakota Monitor) – The North Dakota House of Representatives voted 59-27 on Thursday for a bill to lower ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

Recent health news highlights controversial language restrictions within the FDA, legal actions against vape distributors in ...

Dr. Mehmet Oz, nominated to run the Centers for Medicare & Medicaid Services, will sell shares in Eli Lilly and UnitedHealth.

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Veradigm will add four new directors to its board in an agreement with investor Kent Lake Capital, the healthcare technology company said on Thursday just weeks after concluding a strategic review.

At the time of writing in mid-February, Grayscale Bitcoin Trust ETF (ticker: GBTC) is the ETF with the highest 10-year return ...